FIRST PATIENT ENROLLED IN STAGE 2 OF PIVOTAL STUDY OF SETPOINT MEDICAL’S PIONEERING TECHNOLOGY FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
Results From RESET-RA Study Will Support FDA Submission For Approval Of This Promising Treatment Approach For RA